文献速递血管炎

大血管炎中磁共振血管造影与18F-氟脱氧葡萄糖正电子发射断层扫描的比较

Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.
PubMed 文献 · Ann Rheum Dis · 2018-04-17

前瞻性观察性队列纳入84例患者(巨细胞动脉炎35例、大动脉炎30例、对照19例),共133对影像学检查,比较磁共振血管造影(MRA)与18F-氟脱氧葡萄糖正电子发射断层扫描(PET)在疾病范围和疾病活动度上的一致性。结果显示MRA与PET对疾病范围一致性60%(κ=0.22),对疾病活动度一致性68%(κ=0.30);MRA能更好地显示疾病范围,PET更适合评估血管活动度;临床状态与PET疾病活动度相关(p<0.01),与MRA无关(p=0.70)。

要点

  • MRA与PET对疾病范围一致性60%(κ=0.22),对疾病活动度一致性68%(κ=0.30)。
  • 不一致时MRA显示的病变范围多于PET(304 vs 82个区域,p<0.01)。
  • 临床缓解的69例大血管炎患者中35例(51%)MRA和PET均显示活动性疾病。

核心结论

  • 在大血管炎评估中,MRA与PET提供独特且互补的信息。
  • MRA能更好地显示疾病范围,PET更适合评估血管活动度。
  • 在大血管炎病程中,临床评估与影像学评估常不一致。

研究设计与样本

  • 前瞻性观察性队列研究,纳入巨细胞动脉炎35例、大动脉炎30例及对照19例,共84例患者,贡献133对影像学检查。
  • 影像学与临床评估同时进行,且相互盲法。
  • 一致性采用符合率、Cohen kappa和McNemar检验评估;采用多变量逻辑回归识别与PET扫描活动度相关的MRA特征。

主要发现

  • MRA与PET对疾病范围的一致性为966个动脉区域中580个(60%),Cohen kappa=0.22。
  • 386个不一致区域中,MRA显示病变的区域多于PET(304 vs 82,p<0.01)。
  • MRA与PET对疾病活动度的一致性为90项研究(68%),Cohen kappa=0.30。
  • 不一致的研究中,MRA显示活动性23项,PET显示活动性20项(p=0.76)。
  • MRA上的水肿和壁增厚与PET扫描活动度独立相关;临床状态与PET疾病活动度相关(p<0.01),与MRA无关(p=0.70);69例临床缓解的大血管炎患者中35例(51%)MRA和PET均显示活动性疾病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess agreement between interpretation of magnetic resonance angiography (MRA) and 18F-fluorodeoxyglucose positron emission tomography (PET) for disease extent and disease activity in large-vessel vasculitis (LVV) and determine associations between imaging and clinical assessments. METHODS: Patients with giant cell arteritis (GCA), Takayasu's arteritis (TAK) and comparators were recruited into a prospective, observational cohort. Imaging and clinical assessments were performed concurrently, blinded to each other. Agreement was assessed by per cent agreement, Cohen's kappa and McNemar's test. Multivariable logistic regression identified MRA features associated with PET scan activity. RESULTS: Eighty-four patients (GCA=35; TAK=30; comparator=19) contributed 133 paired studies. Agreement for disease extent between MRA and PET was 580 out of 966 (60%) arterial territories with Cohen's kappa=0.22. Of 386 territories with disagreement, MRA demonstrated disease in more territories than PET (304vs82, p<0.01). Agreement for disease activity between MRA and PET was 90 studies (68%) with Cohen's kappa=0.30. In studies with disagreement, MRA demonstrated activity in 23 studies and PET in 20 studies (p=0.76). Oedema and wall thickness on MRA were independently associated with PET scan activity. Clinical status was associated with disease activity by PET (p<0.01) but not MRA (p=0.70), yet 35/69 (51%) patients with LVV in clinical remission had active disease by both MRA and PET. CONCLUSIONS: In assessment of LVV, MRA and PET contribute unique and complementary information. MRA better captures disease extent, and PET scan is better suited to assess vascular activity. Clinical and imaging-based assessments often do not correlate over the disease course in LVV. TRIAL REGISTRATION NUMBER: NCT02257866.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Quinn KA, Ahlman MA, Malayeri AA, et al. Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. Ann Rheum Dis. 2018. PMID: 29666047. doi:10.1136/annrheumdis-2018-213102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。